2021
DOI: 10.1016/j.jss.2019.12.026
|View full text |Cite
|
Sign up to set email alerts
|

Downregulation of Epac Reduces Fibrosis and Induces Apoptosis Through Akt Signaling in Human Keloid Fibroblasts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 27 publications
0
7
0
Order By: Relevance
“…Interestingly, bioinformatics analysis predicted the potential binding sites between miR-7-5p and Epac1. Simultaneously, our previous study had confirmed that Epac1 played an essential regulatory role in the occurrence and progression of keloids (Lv et al, 2021). Therefore, we choose Epac1 as the target gene of miR-7-5p for further functional verification.…”
Section: Mir-7-5p Regulated Hkfs Proliferation Migration and Invasimentioning
confidence: 87%
“…Interestingly, bioinformatics analysis predicted the potential binding sites between miR-7-5p and Epac1. Simultaneously, our previous study had confirmed that Epac1 played an essential regulatory role in the occurrence and progression of keloids (Lv et al, 2021). Therefore, we choose Epac1 as the target gene of miR-7-5p for further functional verification.…”
Section: Mir-7-5p Regulated Hkfs Proliferation Migration and Invasimentioning
confidence: 87%
“…The ndings indicated that RAPGEF3 is a potential therapeutic target for KOLR. The RAPGEF speci c inhibitor ESI-09 inhibits cell proliferation and migration in different cell lines [31][32][33]. The ndings of the current study showed that apoptosis was promoted and metastasis was inhibited in BxCP-3 cells knockout of RAPGEF3, however, knockout of RAPGEF3 in AsPC-1 cells only inhibited metastasis but did not affect apoptosis.…”
Section: Discussionmentioning
confidence: 53%
“…The findings indicated that RAPGEF3 is a potential therapeutic target for KOLR. The RAPGEF specific inhibitor ESI‐09 inhibits cell proliferation and migration in different cell lines (Almahariq et al, 2013; Kumar et al, 2017; Lv et al, 2021). The findings of the current study showed that apoptosis was promoted and metastasis was inhibited in BxCP‐3 cells knockout of RAPGEF3, however, knockout of RAPGEF3 in AsPC‐1 cells only inhibited metastasis but did not affect apoptosis.…”
Section: Discussionmentioning
confidence: 99%